{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:17:09Z","timestamp":1783477029591,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11030-017-9738-7","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:57:11Z","timestamp":1493081831000},"page":"533-546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Synthesis, pharmacological evaluation and molecular docking of pyranopyrazole-linked 1,4-dihydropyridines as potent positive inotropes"],"prefix":"10.1007","volume":"21","author":[{"given":"Rakesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Lavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Brea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Mestres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok K.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"key":"9738_CR1","first-page":"171","volume-title":"Calcium as cellular regulator","author":"E Carafoli","year":"1999","unstructured":"Carafoli E, Klee C (1999) Calcium as cellular regulator. Oxford University Press, New York, pp 171\u2013200"},{"key":"9738_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513","volume":"13","author":"JE William","year":"2011","unstructured":"William JE, Venkata CSR (2011) Calcium channel blockers. J Clin Hypertens 13:687\u2013689. doi:\n                        10.1111\/j.1751-7176.2011.00513","journal-title":"J Clin Hypertens"},{"key":"9738_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/anie.198107621","volume":"20","author":"F Bossert","year":"1981","unstructured":"Bossert F, Meyer H, Wehinger E (1981) 4-Aryldihydropyridines, a new class of highly active calcium antagonists. Angew Chem Int Edit 20:762\u2013769. doi:\n                        10.1002\/anie.198107621","journal-title":"Angew Chem Int Edit"},{"key":"9738_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5155\/eurjchem.5.1.171-175.943","volume":"5","author":"HS Sohal","year":"2014","unstructured":"Sohal HS, Goyal A, Sharma R, Khare R (2014) One-pot multicomponent synthesis of symmetrical Hantzsch 1,4-dihydropyridine derivatives using glycerol as clean and green solvent. Eur J Med Chem 5:171\u2013175. doi:\n                        10.5155\/eurjchem.5.1.171-175.943","journal-title":"Eur J Med Chem"},{"key":"9738_CR5","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.1016\/j.bmc.2007.06.058","volume":"15","author":"HI Ali","year":"2007","unstructured":"Ali HI, Ashida N, Nagamatsu T (2007) Design, synthesis, antitumor activity, and molecular docking study of novel 2-methylthio-, 2-amino-, and 2-(\n                        $$N$$\n                        \n                            \n                                            \n                                N\n                            \n                        \n                    -substituted amino)-10-alkyl-2-deoxo-5-deazaflavins. Bioorg Med Chem 15:6336\u20136352. doi:\n                        10.1016\/j.bmc.2007.06.058","journal-title":"Bioorg Med Chem"},{"key":"9738_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0968-0896(01)00294-2","volume":"10","author":"MG Pavani","year":"2002","unstructured":"Pavani MG, Nunez M, Brigidi P, Vitali B, Gambari R (2002) Antimicrobial and antitumor activity of \n                        $$N$$\n                        \n                            \n                                            \n                                N\n                            \n                        \n                    -heteroimmine-1,2,3-dithiazoles and their transformation in triazolo-, imidazo-, and pyrazolopirimidines. Bioorg Med Chem 10:449\u2013456. doi:\n                        10.1016\/S0968-0896(01)00294-2","journal-title":"Bioorg Med Chem"},{"key":"9738_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1071\/CH00141","volume":"54","author":"SM Sondhi","year":"2001","unstructured":"Sondhi SM, Johar M, Rajvanshi S, Dastidar SG, Shukla R, Raghubir R, Lown JW (2001) Anticancer, anti-inflammatory and analgesic activity evaluation of heterocyclic compounds synthesized by the reaction of 4-isothiocyanato-4-methylpentan-2-one with substituted \n                        $$o$$\n                        \n                            \n                                            \n                                o\n                            \n                        \n                    -phenylenediamines, \n                        $$o$$\n                        \n                            \n                                            \n                                o\n                            \n                        \n                    -diaminopyridine and (Un)substituted. Aust J Chem 54:69\u201374. doi:\n                        10.1071\/CH00141","journal-title":"Aust J Chem"},{"key":"9738_CR8","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.ejmech.2008.05.025","volume":"44","author":"LB Narayana","year":"2009","unstructured":"Narayana LB, Rao RRA, Rao SP (2009) Synthesis of new 2-substituted pyrido[2,3-\n                        $$d$$\n                        \n                            \n                                            \n                                d\n                            \n                        \n                    ]pyrimidin-4(1H)-ones and their antibacterial activity. Eur J Med Chem 44:1369\u20131376. doi:\n                        10.1016\/j.ejmech.2008.05.025","journal-title":"Eur J Med Chem"},{"key":"9738_CR9","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/j.1747-0285.2011.01233.x","volume":"78","author":"A Trivedi","year":"2011","unstructured":"Trivedi A, Dodiya D, Dholariya B, Kataria V, Bhuva V, Shah V (2011) Synthesis and biological evaluation of some novel 1,4-dihydropyridines as potential antitubercular agents. Chem Biol Drug Des 78:881\u2013886. doi:\n                        10.1111\/j.1747-0285.2011.01233.x","journal-title":"Chem Biol Drug Des"},{"key":"9738_CR10","first-page":"221","volume":"51","author":"CJ Shishoo","year":"2001","unstructured":"Shishoo CJ, Shirsath VS, Rathod IS, Patil MJ, Bhargava SS (2001) Design, synthesis and antihistaminic (H1) activity of some condensed 2-(substituted) arylaminoethylpyrimidine-4-(3\n                        $$H$$\n                        \n                            \n                                            \n                                H\n                            \n                        \n                    )-ones. Arzneim Forsch 51:221\u2013231","journal-title":"Arzneim Forsch"},{"key":"9738_CR11","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1021\/jm960457c","volume":"39","author":"J Jiang","year":"2006","unstructured":"Jiang J, Rhee MA, Melman N, Ji X, Jacobson KA (2006) 6-Phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists. J Med Chem 39:4667\u20134675. doi:\n                        10.1021\/jm960457c","journal-title":"J Med Chem"},{"key":"9738_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1021\/bc9900136","volume":"10","author":"AH Li","year":"2009","unstructured":"Li AH, Chang L, Ji X, Melman N, Jacobson KA (2009) Functionalized congeners of 1,4-dihydropyridines as antagonist molecular probes for A3 adenosine receptors. Bioconjug Chem 10:667\u2013677. doi:\n                        10.1021\/bc9900136","journal-title":"Bioconjug Chem"},{"key":"9738_CR13","doi-asserted-by":"publisher","first-page":"8948","DOI":"10.1021\/jm3008568","volume":"55","author":"JE Bakali","year":"2012","unstructured":"Bakali JE, Gilleron P, Malapel MB, Mansouri R, Muccioli GG, Djouina M, Barczyk A, Klupsch F, Andrzejak V, Lipka E, Furman C, Lambert DM, Chavatte P, Desreumaux P, Millet R (2012) 4-Oxo-1,4-dihydropyridines as selective CB2 cannabinoid receptor ligands. Part 2: Discovery of new agonists endowed with protective effect against experimental colitis. J Med Chem 55:8948\u20138952. doi:\n                        10.1021\/jm3008568","journal-title":"J Med Chem"},{"key":"9738_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0960-894X(99)00696-4","volume":"10","author":"PG Nantermet","year":"2000","unstructured":"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O\u2019Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C (2000) Selective \n                        $$\\upalpha $$\n                        \n                            \n                                            \n                                \u03b1\n                            \n                        \n                    1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones. Bioorg Med Chem Lett 10:1625\u20131628. doi:\n                        10.1016\/S0960-894X(99)00696-4","journal-title":"Bioorg Med Chem Lett"},{"key":"9738_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1248\/bpb.27.415","volume":"27","author":"T Niwa","year":"2004","unstructured":"Niwa T, Shiraga T, Hashimoto T, Kagayama A (2004) Effect of Nilvadipine, a dihydropyridine calcium antagonist, on cytochrome P450 activities in human hepatic microsomes. Biol Pharm Bull 27:415\u2013417. doi:\n                        10.1248\/bpb.27.415","journal-title":"Biol Pharm Bull"},{"key":"9738_CR16","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2174\/092986707781058805","volume":"14","author":"C Viegas-Junior","year":"2007","unstructured":"Viegas-Junior C, Danuello A, Silva DBV, Barreiro EJ, Fraga CA (2007) Molecular hybridization: a useful tool in the design of new drug prototypes. Curr Med Chem 14:1829\u20131829. doi:\n                        10.2174\/092986707781058805","journal-title":"Curr Med Chem"},{"key":"9738_CR17","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1248\/cpb.40.2547","volume":"40","author":"LJ Huang","year":"1992","unstructured":"Huang LJ, Hour MJ, Teng CM, Kuo SC (1992) Synthesis and antiplatelet activities of \n                        $$N$$\n                        \n                            \n                                            \n                                N\n                            \n                        \n                    -arylmethyl-3,4-dimethylpyrano[2,3-\n                        $$c$$\n                        \n                            \n                                            \n                                c\n                            \n                        \n                    ]pyrazol-6-one derivatives. Chem Pharm Bull 40:2547\u20132551","journal-title":"Chem Pharm Bull"},{"key":"9738_CR18","first-page":"400","volume":"2","author":"NR Mohamed","year":"2010","unstructured":"Mohamed NR, Khaireldin NY, Fahmyb AF, El-Sayeda AAF (2010) Facile synthesis of fused nitrogen containing heterocycles as anticancer agents. Der Pharm Chem 2:400\u2013417","journal-title":"Der Pharm Chem"},{"key":"9738_CR19","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1248\/cpb.29.3522","volume":"29","author":"T Ueda","year":"1981","unstructured":"Ueda T, Mase H, Oda N, Ito I (1981) Synthesis of pyrazolone derivatives. XXXIX. Synthesis and analgesic activity of pyrano[2,3-\n                        $$c$$\n                        \n                            \n                                            \n                                c\n                            \n                        \n                    ]pyrazoles. Chem Pharm Bull 29:3522\u20133528. doi:\n                        10.1248\/cpb.29.3522","journal-title":"Chem Pharm Bull"},{"key":"9738_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1021\/jm00370a020","volume":"27","author":"SC Kuo","year":"1984","unstructured":"Kuo SC, Huang LJ, Nakamura H (1984) Synthesis and analgesic and antiinflammatory activities of 3,4-dimethylpyrano[2,3-\n                        $$c$$\n                        \n                            \n                                            \n                                c\n                            \n                        \n                    ]pyrazol-6-one derivatives. J Med Chem 27:539\u2013544. doi:\n                        10.1021\/jm00370a020","journal-title":"J Med Chem"},{"key":"9738_CR21","first-page":"143","volume":"54","author":"SE Assiery","year":"2004","unstructured":"Assiery SE, Sayed GH, Fouda A (2004) Synthesis of some new annulated pyrazolo-pyrido (or pyrano) pyrimidine, pyrazolopyridine and pyranopyrazole derivatives. Acta Pharma 54:143\u2013150","journal-title":"Acta Pharma"},{"key":"9738_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/00397910500328886","volume":"36","author":"MM Mohammad","year":"2006","unstructured":"Mohammad MM, Mohammad RJ, Mohammad B (2006) Facile synthesis of pyrano[2,3-\n                        $$c$$\n                        \n                            \n                                            \n                                c\n                            \n                        \n                    ]pyrazol-6-one derivatives under microwave irradiation in solvent-free conditions. Synth Comm 36:51\u201358. doi:\n                        10.1080\/00397910500328886","journal-title":"Synth Comm"},{"key":"9738_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/312121a0","volume":"312","author":"M Noda","year":"1984","unstructured":"Noda M, Shimizu S, Tanabe T, Takai T, Kayano T, Ikeda T, Takahashi H, Nakayama H, Kanaoka Y, Minamino N (1984) Primary structure of electrophorus electricus sodium channel deduced from cDNA sequence. Nature 312:121\u2013127. doi:\n                        10.1038\/312121a0","journal-title":"Nature"},{"key":"9738_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/328313a0","volume":"328","author":"T Tanabe","year":"1987","unstructured":"Tanabe T, Takeshima H, Mikami A, Flockerzi V, Takahashi H, Kanqawa A, Kojima M, Matsuo H, Hirose T, Numa S (1987) Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 328:313\u2013318. doi:\n                        10.1038\/328313a0","journal-title":"Nature"},{"key":"9738_CR25","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.2441471","volume":"237","author":"BL Tempel","year":"1987","unstructured":"Tempel BL, Papazian DM, Schwarz TL, Jan LY, Jan YN (1987) Sequence of a probable potassium channel component encoded at Shaker locus of Drosophila. Science 237:770\u2013775. doi:\n                        10.1126\/science.2441471","journal-title":"Science"},{"key":"9738_CR26","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749. doi:\n                        10.1021\/jm0306430","journal-title":"J Med Chem"},{"issue":"7","key":"9738_CR27","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47(7):1750\u20131759. doi:\n                        10.1021\/jm030644s","journal-title":"J Med Chem"},{"issue":"2","key":"9738_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/ci800324m","volume":"49","author":"TA Halgren","year":"2009","unstructured":"Halgren TA (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49(2):377\u2013389. doi:\n                        10.1021\/ci800324m","journal-title":"J Chem Inf Model"},{"key":"9738_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1529\/biophysj.104.048173","volume":"88","author":"DB Tikhonov","year":"2005","unstructured":"Tikhonov DB, Zhorov BS (2005) Modeling P-loops domain of sodium channel: homology with potassium channels and interaction with ligands. Biophys J 88:184\u2013197. doi:\n                        10.1529\/biophysj.104.048173","journal-title":"Biophys J"},{"key":"9738_CR30","doi-asserted-by":"publisher","first-page":"17594","DOI":"10.1074\/jbc.M800141200","volume":"283","author":"DB Tikhonov","year":"2008","unstructured":"Tikhonov DB, Zhorov BS (2008) Molecular modeling of benzothiazepine binding in the L-type calcium channel. J Biol Chem 283:17594\u201317604. doi:\n                        10.1074\/jbc.M800141200","journal-title":"J Biol Chem"},{"key":"9738_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1124\/mol.64.2.235","volume":"64","author":"S Yamaguchi","year":"2003","unstructured":"Yamaguchi S, Zhorov BS, Yoshioka K, Nagao T, Ichijo H, Adachi-Akahane S (2003) Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5\u2013S6 linker of L-type Ca\n                        $$^{2+}$$\n                        \n                            \n                                            \n                                \n                                    \n                                    \n                                        2\n                                        +\n                                    \n                                \n                            \n                        \n                     channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca\n                        $$^{2+}$$\n                        \n                            \n                                            \n                                \n                                    \n                                    \n                                        2\n                                        +\n                                    \n                                \n                            \n                        \n                     channel agonists. Mol Pharmacol 64:235\u2013248. doi:\n                        10.1124\/mol.64.2.235","journal-title":"Mol Pharmacol"},{"key":"9738_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/978-1-60761-839-3_19","volume":"672","author":"D Vidal","year":"2011","unstructured":"Vidal D, Garcia-Serna R, Mestres J (2011) Ligand-based approaches to in silico pharmacology. Methods Mol Biol 672:489\u2013502. doi:\n                        10.1007\/978-1-60761-839-3_19","journal-title":"Methods Mol Biol"},{"key":"9738_CR33","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1021\/acs.chemrestox.5b00260","volume":"28","author":"R Garcia-Serna","year":"2015","unstructured":"Garcia-Serna R, Vidal D, Remez N, Mestres J (2015) Large-scale predictive drug safety: from structural alerts to biological mechanisms. Chem Res Toxicol 28:1875\u20131887. doi:\n                        10.1021\/acs.chemrestox.5b00260","journal-title":"Chem Res Toxicol"},{"key":"9738_CR34","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, Cibri\u00e1n-Uhalte E, Davies M, Dedman N, Karlsson A, Magari\u00f1os MP, Overington JP, Papadatos G, Smit I, Leach AR (2017) The ChEMBL database in 2017. Nucleic Acids Res 45:D945\u2013D954. doi:\n                        10.1093\/nar\/gkw1074","journal-title":"Nucleic Acids Res"},{"key":"9738_CR35","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bbrc.2010.04.149","volume":"396","author":"T Matsui","year":"2010","unstructured":"Matsui T, Takeuchi M, Yamagishi S (2010) Nifedipine, a calcium channel blocker, inhibits inflammatory and fibrogenic gene expressions in advanced glycation end product (AGE)-exposed fibroblasts via mineralocorticoid receptor antagonistic activity. Biochem Biophys Res Commun 396:566\u2013570. doi:\n                        10.1016\/j.bbrc.2010.04.149","journal-title":"Biochem Biophys Res Commun"},{"key":"9738_CR36","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118:11225\u201311236. doi:\n                        10.1021\/ja9621760","journal-title":"J Am Chem Soc"},{"key":"9738_CR37","unstructured":"SiteMap (2009) version 2.3, Schr\u00f6dinger. LLC, New York, NY"},{"key":"9738_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","volume":"25","author":"MJ Keiser","year":"2007","unstructured":"Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK (2007) Relating protein pharmacology by ligand chemistry. Nat Biotechnol 25:197\u2013206. doi:\n                        10.1038\/nbt1284","journal-title":"Nat Biotechnol"},{"key":"9738_CR39","doi-asserted-by":"publisher","unstructured":"Brians\u00f3 F, Carrascosa MC, Oprea TI, Mestres J (2011) Cross-pharmacology analysis of G protein-coupled receptors. Curr Top Med Chem 11:1956\u20131963. doi:\n                        10.2174\/156802611796391285","DOI":"10.2174\/156802611796391285"},{"key":"9738_CR40","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1016\/j.bmc.2010.03.048","volume":"18","author":"FM Areias","year":"2010","unstructured":"Areias FM, Brea J, Gregori-Puigjan\u00e9 E, Zaki MEA, Carvalho MA, Dom\u00ednguez E, Guti\u00e9rrez-de-Ter\u00e1n H, Proen\u00e7a MF, Loza MI, Mestres J (2010) In silico directed chemical probing of the adenosine receptor family. Bioorg Med Chem 18:3043\u20133052. doi:\n                        10.1016\/j.bmc.2010.03.048","journal-title":"Bioorg Med Chem"},{"key":"9738_CR41","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/clpt.2011.177","volume":"90","author":"J Mestres","year":"2011","unstructured":"Mestres J, Seifert SA, Oprea TI (2011) Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome. Clin Pharmacol Ther 90:662\u2013665. doi:\n                        10.1038\/clpt.2011.177","journal-title":"Clin Pharmacol Ther"},{"key":"9738_CR42","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1021\/cb300317y","volume":"7","author":"AA Antol\u00edn","year":"2012","unstructured":"Antol\u00edn AA, Jalencas X, Y\u00e9lamos J, Mestres J (2012) Identification of PIM kinases as novel targets for PJ34 with confounding effects in PARP biology. ACS Chem Biol 7:1962\u20131967. doi:\n                        10.1021\/cb300317y","journal-title":"ACS Chem Biol"},{"key":"9738_CR43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1021\/cb500393m","volume":"10","author":"AA Antol\u00edn","year":"2015","unstructured":"Antol\u00edn AA, Mestres J (2015) Distant polypharmacology among MLP chemical probes. ACS Chem Biol 10:395\u2013400. doi:\n                        10.1021\/cb500393m","journal-title":"ACS Chem Biol"},{"key":"9738_CR44","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.1021\/jm301055g","volume":"55","author":"M Montolio","year":"2012","unstructured":"Montolio M, Gregori-Puigjan\u00e9 E, Pineda D, Mestres J, Navarro P (2012) Identification of small molecule inhibitors of amyloid \n                        $$\\upbeta $$\n                        \n                            \n                                            \n                                \u03b2\n                            \n                        \n                    -induced neuronal apoptosis acting through the imidazoline I(2) receptor. J Med Chem 55:9838\u20139846. doi:\n                        10.1021\/jm301055g","journal-title":"J Med Chem"},{"key":"9738_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1006\/taap.1996.0075","volume":"137","author":"CL Waller","year":"1996","unstructured":"Waller CL, Juma BW, Gray LE Jr, Kelce WR (1996) Three-dimensional quantitative structure-activity relationships for androgen receptor ligands. Toxicol Appl Pharmacol 137:219\u2013227. doi:\n                        10.1006\/taap.1996.0075","journal-title":"Toxicol Appl Pharmacol"},{"key":"9738_CR46","doi-asserted-by":"publisher","first-page":"9780","DOI":"10.1016\/j.bmc.2008.09.067","volume":"16","author":"A Stefanachi","year":"2008","unstructured":"Stefanachi A, Nicolotti O, Leonetti F, Cellamare S, Campagna F, Loza MI, Brea JM, Mazza F, Gavuzzo E, Carotti A (2008) 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships. Bioorg Med Chem 16:9780\u20139789. doi:\n                        10.1016\/j.bmc.2008.09.067","journal-title":"Bioorg Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-017-9738-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-017-9738-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-017-9738-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T03:04:30Z","timestamp":1502507070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-017-9738-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["9738"],"URL":"https:\/\/doi.org\/10.1007\/s11030-017-9738-7","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,25]]}}}